Edap TMS SA (EDAP)
2.69
-0.17
(-5.94%)
USD |
NASDAQ |
Nov 04, 16:00
2.72
+0.03
(+1.12%)
After-Hours: 20:00
Edap TMS Enterprise Value: 70.68M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 04, 2024 | 70.68M |
November 01, 2024 | 76.99M |
October 31, 2024 | 78.47M |
October 30, 2024 | 81.81M |
October 29, 2024 | 82.18M |
October 28, 2024 | 78.47M |
October 25, 2024 | 72.16M |
October 24, 2024 | 64.37M |
October 23, 2024 | 60.29M |
October 22, 2024 | 67.90M |
October 21, 2024 | 73.28M |
October 18, 2024 | 71.42M |
October 17, 2024 | 69.20M |
October 16, 2024 | 72.16M |
October 15, 2024 | 72.91M |
October 14, 2024 | 71.05M |
October 11, 2024 | 68.08M |
October 10, 2024 | 68.08M |
October 09, 2024 | 68.08M |
October 08, 2024 | 70.31M |
October 07, 2024 | 70.68M |
October 04, 2024 | 68.82M |
October 03, 2024 | 66.60M |
October 02, 2024 | 68.45M |
October 01, 2024 | 71.42M |
Date | Value |
---|---|
September 30, 2024 | 65.48M |
September 27, 2024 | 75.13M |
September 26, 2024 | 77.36M |
September 25, 2024 | 79.21M |
September 24, 2024 | 81.81M |
September 23, 2024 | 81.44M |
September 20, 2024 | 84.04M |
September 19, 2024 | 84.04M |
September 18, 2024 | 85.15M |
September 17, 2024 | 87.75M |
September 16, 2024 | 91.09M |
September 13, 2024 | 91.09M |
September 12, 2024 | 89.97M |
September 11, 2024 | 90.72M |
September 10, 2024 | 90.34M |
September 09, 2024 | 85.15M |
September 06, 2024 | 85.89M |
September 05, 2024 | 87.38M |
September 04, 2024 | 89.79M |
September 03, 2024 | 100.36M |
August 30, 2024 | 104.44M |
August 29, 2024 | 91.83M |
August 28, 2024 | 81.81M |
August 27, 2024 | 77.36M |
August 26, 2024 | 86.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
32.14M
Minimum
Mar 18 2020
400.67M
Maximum
Mar 03 2023
182.37M
Average
179.05M
Median
Jan 19 2021
Enterprise Value Benchmarks
DBV Technologies SA | 9.250M |
Genfit SA | 288.04M |
Cellectis SA | -52.07M |
Adaptimmune Therapeutics PLC | 18.55M |
Akari Therapeutics PLC | 25.86M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -6.603M |
Revenue (Quarterly) | 17.00M |
Total Expenses (Quarterly) | 23.62M |
EPS Diluted (Quarterly) | -0.1723 |
Gross Profit Margin (Quarterly) | 37.48% |
Profit Margin (Quarterly) | -38.83% |
Earnings Yield | -20.91% |
Normalized Earnings Yield | -20.95 |